Brainomix, a leader in artificial intelligence (AI) imaging software for stroke, has announced a strategic partnership with Medtronic Neurovascular, a global medical technology company, to improve stroke care across Western Europe. This collaboration aims to integrate advanced AI solutions into clinical practice, expanding access to life-saving treatments and improving patient outcomes.
The Brainomix 360 Stroke platform utilizes state-of-the-art AI algorithms to provide real-time interpretation of brain scans, aiding in treatment and transfer decisions for stroke patients. In the largest real-world evaluation of stroke AI, involving data from over 450,000 patients across England over a five-year period, results showed a doubling of thrombectomy rates at Brainomix sites, with an additional 37% increase compared to non-evaluation sites.
By combining Brainomix’s AI-powered imaging technology with Medtronic’s expertise in neurovascular treatments, the partnership represents a significant advancement in stroke care. The collaboration will support faster, more accurate diagnoses, enabling healthcare professionals to make better-informed decisions and deliver life-saving interventions more efficiently.
Dr. Michalis Papadakis, CEO and Co-Founder of Brainomix, emphasized the shared vision of both companies:
“This partnership with Medtronic is a natural fit, with the leading neurovascular device provider joining forces with the leading stroke AI imaging partner, both aligned around a mutual commitment towards improving stroke care for all patients. We have demonstrated that our software impacts treatment rates, and working with Medtronic, we now have an opportunity together to deliver a solution for stroke networks across Europe that will enable more patients to get access to vital stroke treatments.”
Dr. Alex Solich, Senior Consultant for Neurointervention at Karolinska University Hospital and Örebro Hospital, highlighted the potential impact on patient outcomes:
“As a stroke physician, I see firsthand the critical importance of speed and precision in delivering life-saving treatment. That’s why I’m genuinely excited about the partnership between Medtronic Neurovascular and Brainomix. Combining Medtronic’s proven neurovascular technologies with Brainomix’s AI-driven imaging has the potential to make a real difference—not just in streamlining workflows, but in giving patients a better chance at recovery. Knowing that we are moving toward more efficient, data-driven decision-making gives me great confidence that we can continue to push the boundaries of stroke care and improve outcomes for countless patients.”
Key Benefits of the Partnership
- Transforming Treatment Regionally: Medtronic’s established presence in Western Europe will accelerate the adoption of Brainomix’s AI technology, ensuring that life-saving innovations reach more hospitals and healthcare providers across the region.
- Enhanced Diagnostic Accuracy: Integrating Brainomix’s AI-powered imaging software with Medtronic’s neurovascular solutions will provide healthcare professionals with highly precise diagnostic tools, enabling quicker and more informed decisions crucial for timely stroke treatment.
- Optimized Clinical Workflows: By simplifying and accelerating stroke detection and intervention, this partnership will help alleviate the burden on healthcare providers and enhance efficiency across hospital networks.
This partnership underscores a mutual commitment to advancing stroke care and improving patient outcomes through innovative technology and collaboration.
